Trials / Completed
CompletedNCT01791322
NovellusDx Tissue Collection Protocol
An Observational Study to Assess the Oncogenic Status of Colorectal Cancer Patients That Have Undergone Surgery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Fore Biotherapeutics · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
NovellusDx is developing a diagnostic platform for the personalized cancer therapy based on patient derived tumor tissue. The assay is able to sense activating mutations by monitoring their effect on a chip-based device.
Conditions
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2013-02-13
- Last updated
- 2018-03-29
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01791322. Inclusion in this directory is not an endorsement.